Description
BSE lists 43,04,000 new equity shares of DR LALCHANDANI LABS LIMITED issued on rights basis, effective March 6, 2026. Shares are ranked pari-passu with existing equity shares.
Summary
BSE has listed 43,04,000 new equity shares of DR LALCHANDANI LABS LIMITED (Scrip Code: 541299) issued on a rights basis at par value of Rs. 10/- each. These shares are permitted to trade on the Exchange effective Friday, March 6, 2026.
Key Points
- 43,04,000 equity shares of Rs. 10/- each issued at par on rights basis
- ISIN: INE871Z01013
- Distribution numbers: 4333069 to 8637068
- Date of Allotment: 02/03/2026
- Shares rank pari-passu with existing equity shares of the company
- Trading permitted from March 6, 2026
Regulatory Changes
No regulatory changes. This is a standard listing notice for newly allotted securities.
Compliance Requirements
Trading members of BSE are informed to note the listing and permit trading in these new securities from the effective date.
Important Dates
- Date of Allotment: March 2, 2026
- Effective Date for Trading: March 6, 2026 (Friday)
Impact Assessment
Limited market impact. The listing of 43,04,000 rights-issue shares increases the total tradable equity of DR LALCHANDANI LABS LIMITED. The shares carry equal rights as existing shares (pari-passu), so no dilution of rights for existing shareholders beyond the rights issue itself. Impact is confined to existing shareholders and traders of Scrip Code 541299.
Impact Justification
Routine listing of new equity shares issued on rights basis for a single company; no regulatory changes or broad market impact.